Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE

Scitech Produtos Medicos

Status: Completed

Conditions: Coronary Artery Disease

Treatments: Device: Angioplasty

Study type: Observational

Funder types: Industry

Identifiers

NCT03471234

SCI-CO-01

Details and patient eligibility

About

Prospective, multicenter, single arm registry to monitor post-market clinical outcomes of patients treated with Inspiron Sirolimus-Eluting Stent with Biodegradable Polymer.

Full description

Prospective, multicenter, single arm registry to assess the safety and performance of Inspiron Sirolimus-Eluting Stent with Biodegradable Polymer for the treatment of "real world" patients.

Enrollment: 299 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All individuals aged over 18 years who signed the informed consent and had lesions in native coronary arteries treated only with Inspiron Sirolimus-Eluting stent.

Exclusion criteria

• Saphenous vein grafts or Mammary lesions;
• Individuals who have been treated within the last 6 months with another stent;
• Acute myocardial infarction with ST segment elevation;
• Chronic Total Occlusion